BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19969511)

  • 1. New specific molecular targets for radio-chemotherapy of rectal cancer.
    Snipstad K; Fenton CG; Kjaeve J; Cui G; Anderssen E; Paulssen RH
    Mol Oncol; 2010 Feb; 4(1):52-64. PubMed ID: 19969511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.
    Ghadimi BM; Grade M; Difilippantonio MJ; Varma S; Simon R; Montagna C; Füzesi L; Langer C; Becker H; Liersch T; Ried T
    J Clin Oncol; 2005 Mar; 23(9):1826-38. PubMed ID: 15774776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
    Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
    Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma.
    Brettingham-Moore KH; Duong CP; Greenawalt DM; Heriot AG; Ellul J; Dow CA; Murray WK; Hicks RJ; Tjandra J; Chao M; Bui A; Joon DL; Thomas RJ; Phillips WA
    Clin Cancer Res; 2011 May; 17(9):3039-47. PubMed ID: 21224373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.
    Supiot S; Gouraud W; Campion L; Jezéquel P; Buecher B; Charrier J; Heymann MF; Mahé MA; Rio E; Chérel M
    World J Gastroenterol; 2013 Jun; 19(21):3249-54. PubMed ID: 23745026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients.
    Agostini M; Zangrando A; Pastrello C; D'Angelo E; Romano G; Giovannoni R; Giordan M; Maretto I; Bedin C; Zanon C; Digito M; Esposito G; Mescoli C; Lavitrano M; Rizzolio F; Jurisica I; Giordano A; Pucciarelli S; Nitti D
    Cancer Biol Ther; 2015; 16(8):1160-71. PubMed ID: 26023803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation induces different changes in expression profiles of normal rectal tissue compared with rectal carcinoma.
    Nagtegaal ID; Gaspar CG; Peltenburg LT; Marijnen CA; Kapiteijn E; van de Velde CJ; Fodde R; van Krieken JH
    Virchows Arch; 2005 Feb; 446(2):127-35. PubMed ID: 15602683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.
    Flanagan L; Kehoe J; Fay J; Bacon O; Lindner AU; Kay EW; Deasy J; McNamara DA; Prehn JH
    Radiat Oncol; 2015 Jun; 10():131. PubMed ID: 26071313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
    Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
    Yao YF; Du CZ; Chen N; Chen P; Gu J
    Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.
    Rödel C; Grabenbauer GG; Papadopoulos T; Bigalke M; Günther K; Schick C; Peters A; Sauer R; Rödel F
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):294-303. PubMed ID: 11872273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
    Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
    Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
    Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray profiling of mononuclear peripheral blood cells identifies novel candidate genes related to chemoradiation response in rectal cancer.
    Palma P; Cuadros M; Conde-Muíño R; Olmedo C; Cano C; Segura-Jiménez I; Blanco A; Bueno P; Ferrón JA; Medina P
    PLoS One; 2013; 8(9):e74034. PubMed ID: 24040155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
    Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
    Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal cancer: changing patterns of referral for radiation therapy 1982-1997.
    Stevens G; Firth I; Solomon M; Saw R; Glenn D; Eyers A; West R
    Aust N Z J Surg; 2000 Aug; 70(8):553-9. PubMed ID: 10945546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
    Petty RD; Samuel LM; Murray GI; MacDonald G; O'Kelly T; Loudon M; Binnie N; Aly E; McKinlay A; Wang W; Gilbert F; Semple S; Collie-Duguid ES
    BMC Cancer; 2009 Dec; 9():434. PubMed ID: 20003335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma.
    Ambrosini-Spaltro A; Salvi F; Miglio R; Liguori L; Fabbri C; Piemontese A; Martelli O; Frezza GP; Foschini MP
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):227-31. PubMed ID: 18301248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas].
    Tannapfel A; Nüsslein S; Katalinic A; Köckerling F; Wittekind C; Fietkau R
    Strahlenther Onkol; 1998 Jun; 174(6):295-9. PubMed ID: 9645209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.